脾脏硬度和体积预测肝细胞癌患者肝切除术后发生肝功能衰竭的价值

陈皓; 马俊永; 钱利强; 尹国文

doi:10.3969/j.issn.1001-5256.2019.12.017

脾脏硬度和体积预测肝细胞癌患者肝切除术后发生肝功能衰竭的价值

DOI: 10.3969/j.issn.1001-5256.2019.12.017

1. 南通大学附属吴江医院,苏州市第九人民医院肝胆外科
2. 第二军医大学第三附属医院肝外四科
3. 江苏省肿瘤医院介入科

基金项目:

江苏省卫生计生委2017年医学科研课题指导性项目(Z201704)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1027
- HTML全文浏览量: 26
- PDF下载量: 243
- 被引次数: 0
出版历程
- 收稿日期: 2019-07-09
- 出版日期: 2019-12-20

Value of spleen stiffness and spleen volume in predicting posthepatectomy liver failure in patients with hepatocellular carcinoma

Department of Hepatobiliary Surgery,Wujiang Hospital Affiliated to Nantong University &Suzhou Ninth People's Hospital

Research funding:

摘要

摘要: 目的评估脾脏硬度（SS）和脾脏体积（SV）在肝细胞癌（HCC）患者接受肝切除术后肝功能衰竭（PHLF）中的预测价值。方法收集2014年5月-2019年2月于苏州市第九人民医院和第二军医大学第三附属医院接受肝切除术的HCC患者的临床数据。所有患者术前测量SS、肝脏硬度（LS）、SV、剩余残肝体积（FRLV）和炎症指标等。计量资料两组间比较采用独立样本t检验;采用Pearson相关性分析SS与LS、SV的相关性;用单因素和多因素logistic回归分析评价PHLF发生的影响因素。通过受试者工作特征曲线（ROC曲线）评估SS、SV/FRLV和入肝血流阻断（HIO）的临床价值,计算ROC曲线下面积（AUC）、敏感度和特异度。结果最终纳入148例HCC患者,其中21例（14. 2%）发生PHLF。根据术后病理报告,73例（49. 3%）患者发现肝硬化。肝硬化与非肝硬化患者比较,SV、LS、SS差异均有统计学意义（t值分别为13. 610、6. 952、20. 580,P值均<0. 001）。相关性分析结果显示,SS与LS、SV均呈正相关（r值分别为0. 650、0. 453,P值分别为0....
- 癌,肝细胞 /
- 脾脏硬度 /
- 脾脏体积 /
- 肝切除术 /
- 肝功能衰竭
Abstract: Objective To investigate the value of spleen stiffness( SS) and spleen volume( SV) in predicting posthepatectomy liver failure( PHLF) in patients with hepatocellular carcinoma( HCC). Methods Related clinical data were collected from the patients with HCC who underwent hepatectomy in Suzhou Ninth People's Hospital and The Third Affiliated Hospital of Second Military Medical University from May2014 to February 2019. SS,liver stiffness( LS),SV,residual remnant liver volume( FRLV),and inflammation markers were measured for all patients before surgery. The independent samples t-test was used for comparison of continuous data between two groups; a Pearson correlation analysis was used to investigate the correlation of SS with LS and SV; univariate and multivariate logistic regression analyses were used to identify the influencing factors for the development of PHLF. The receiver operating characteristic( ROC) curve was used to evaluate the clinical value of SS,SV/FRLV,and hepatic inflow occlusion( HIO),and the area under the ROC curve( AUC),sensitivity,and specificity were calculated. Results A total of 148 patients with HCC were enrolled,among whom 21( 14. 2%) developed PHLF. Postoperative pathology revealed liver cirrhosis in 73 patients( 49. 3%). There were significant differences in SV,LS,and SS between the patients with liver cirrhosis and those without liver cirrhosis( t = 13. 610,6. 952,and 20. 580,all P < 0. 001). The correlation analysis showed that SS was positively correlated with LS and SV( r = 0. 650 and 0. 453,P = 0. 002 and 0. 005). The univariate analysis showed that tumor diameter,liver cirrhosis,neutrophil/lymphocyte ratio,LS,SS,SV/FRLV,time of operation,blood transfusion,and HIO duration were associated with the development of PHLF( all P < 0. 05),and the multivariate logistic regression analysis showed that SV/FRLV( hazard ratio[HR]= 26. 564,95% confidence interval [CI]: 1. 611-422. 541,P < 0. 001),SS( HR = 1. 018,95% CI: 1. 014-1. 154,P =0. 008),and HIO duration( HR = 1. 045,95% CI: 1. 012-1. 084,P = 0. 002) were independent risk factors for PHLF. The ROC curve analysis showed that SV/FRLV had an AUC of 0. 867( 95% CI: 0. 755-0. 926,P < 0. 001),a sensitivity of 0. 783,and a specificity of0. 919 in predicting PHLF; SS had an AUC of 0. 856( 95% CI: 0. 715-0. 984,P < 0. 001),a sensitivity of 0. 673,and a specificity of0. 862 in predicting PHLF; HIO had an AUC of 0. 694( 95% CI: 0. 542-0. 862,P = 0. 003),a sensitivity of 0. 696,and a specificity of0. 741 in predicting PHLC. Conclusion SS and SV/FRLV can help to predict the development of PHLF in patients with HCC.
- carcinoma,hepatocellular /
- spleen stiffness /
- spleen volume /
- hepatectomy /
- liver failure

HTML全文

参考文献(17)

[1] PREDA CM,BAICUS C,SANDRA I,et al. Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy[J]. United European Gastroenterol J,2019,7(5):699-708.

[2] THORSEN T,SOLHEIM JM,LABORI KJ,et al. Liver transplantation as a lifesaving procedure for posthepatectomy liver failure and iatrogenic liver injuries[J]. Langenbecks Arch Surg,2019,404(3):301-308.

[3] ZHOU JM,BAN ZC,LI Y,et al. Value of liver stiffnessspleen diameter-to-platelet ratio score in predicting esophageal varices in patients with liver cirrhosis[J]. J Clin Hepatol,2018,34(11):2341-2344.(in Chinese)周佳美，班志超，李艳，等．肝硬度×脾脏直径/血小板评分对肝硬化食管静脉曲张的预测价值[J]．临床肝胆病杂志，2018,34(11):2341-2344.

[4] TAKUMA Y,NOUSO K,MORIMOTO Y,et al. Portal hypertension in patients with liver cirrhosis:Diagnostic accuracy of spleen stiffness[J]. Radiology,2016,279(2):609-619.

[5] GRUTTADAURIA S,PAGANO D,LIOTTA R,et al. Liver volume restoration and hepatic microarchitecture in small-forsize syndrome[J]. Ann Transplant,2015,20:381-389.

[6] PENG W,LI JW,ZHANG XY,et al. A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma[J]. PLo S One,2019,14(7):e0219219.

[7] CESCON M,CUCCHETTI A,COLECCHIA A,et al. Reply to letter:“value of transient elastography measured with fibroscan in predicting the outcome of hepatic resection for hepatocellular carcinoma”[J]. Ann Surg,2015,261(4):e105-e106.

[8] NISHIO T,TAURA K,KOYAMA Y,et al. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma[J]. Surgery,2016,159(2):399-408.

[9] WU D,CHEN E,LIANG T,et al. Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma[J]. Medicine(Baltimore),2017,96(34):e7864.

[10] MARASCO G,COLECCHIA A,COLLI A,et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection[J]. J Hepatol,2019,70(3):440-448.

[11] de SANTIS A,NARDELLI S,BASSANELLI C,et al. Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt[J]. J Gastroenterol Hepatol,2018,33(3):704-709.

[12] SHEN Y,WU SD,WU L,et al. The prognostic role of liver stiffness in patients with chronic liver disease:A systematic review and dose-response meta-analysis[J]. Hepatol Int,2019,13(5):560-572.

[13] BERZIGOTTI A,SEIJO S,ARENA U,et al. Elastography,spleen size,and platelet count identify portal hypertension in patients with compensated cirrhosis[J]. Gastroenterology,2013,144(1):102-111.

[14] MA M,NIU TT,SHAO L,et al. Hepatic transcatheter arterial chemoembolization combined with stereotactic radia-tion therapy of primary liver cancer[J]. Trauma and Crit Medicine,2017,5(1):32-35.(in Chinese)马明，牛婷婷，邵亮，等．肝动脉化疗栓塞术联合立体定向放疗治疗较大原发性肝癌临床研究[J]．创伤与急危重病医学，2017,5(1):32-35.

[15] HU XW,DING TL,HONG ZX. Therapeutic effect of partial hepatectomy combined with radiofrequency ablation for primary hepatocellular carcinoma[J]. Trauma Crit Med,2018,6(4):226-227,230.(in Chinese)胡雄伟，丁同领，洪智贤．部分肝切除术联合射频消融术治疗原发性肝癌疗效分析[J]．创伤与急危重病医学，2018,6(4):226-227,230.

[16] TRUANT S,EL AMRANI M,BAILLET C,et al. Laparoscopic partial ALPPS:Much better than ALPPS![J]. Ann Hepatol,2019,18(1):269-273.

[17] CHEN X,ZHAI J,CAI X,et al. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis[J]. Br J Surg,2012,99(12):1701-1710.

施引文献

资源附件(0)

访问统计